Avient (NYSE: AVNT) CEO granted 63,480 restricted stock units vesting 2027-2029

Rhea-AI Filing Summary

Ashish Khandpur K reported acquisition or exercise transactions in this Form 4 filing.

Avient Corp reported that Chairman, President & CEO Ashish K. Khandpur received a grant of 63,480 restricted stock units. Each unit represents a contingent right to receive one share of Avient common stock, vesting in substantially equal installments on February 20 of 2027, 2028 and 2029.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ashish Khandpur K

(Last) (First) (Middle)

AVIENT CORPORATION

33587 WALKER ROAD

(Street)

AVON LAKE OH 44012

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVIENT CORP [ AVNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/20/2026		A		63,480		(2)	(2)	Common Stock	63,480	$0	63,480	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Avient common stock.

2. The restricted stock units vest in substantially equal installments on each of February 20, 2027, February 20, 2028 and February 20, 2029, unless earlier vested or terminated pursuant to the terms of the grant agreement.

	/s/ Robert K. James, Power of Attorney for Ashish K. Khandpur	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Avient (AVNT) report on this Form 4?

Avient reported that its Chairman, President & CEO Ashish K. Khandpur received a grant of 63,480 restricted stock units. These units are a form of equity compensation that convert into common shares if vesting conditions are satisfied over time.

How many restricted stock units were granted to the Avient (AVNT) CEO?

Ashish K. Khandpur was granted 63,480 restricted stock units of Avient common stock. This entire amount was reported as directly owned following the transaction, reflecting a single equity award rather than multiple separate grants.

When do the newly granted Avient (AVNT) restricted stock units vest?

The restricted stock units vest in substantially equal installments on February 20, 2027, February 20, 2028, and February 20, 2029. Vesting requires continued satisfaction of the grant agreement’s terms, and units generally convert into common shares only as they vest.

What does each Avient (AVNT) restricted stock unit represent?

Each restricted stock unit represents a contingent right to receive one share of Avient common stock. The units do not become actual shares until they vest under the grant agreement, aligning executive compensation with long-term shareholder interests.

Is this Avient (AVNT) Form 4 transaction a purchase or a grant?

The Form 4 reports a grant or award acquisition, not an open-market share purchase. The 63,480 restricted stock units were awarded as equity compensation to the CEO, with no price paid per unit and vesting scheduled over three future dates.